PK4

PK4 (PF3D7_0628200) is a Plasmodium falciparum eukaryotic initiation factor-2α (eIF-2α) kinase that controls the translational state of the parasite by phosphorylating the regulatory Ser59 of parasite eIF2α, thereby arresting global protein synthesis during the erythrocytic cycle (PMID:9371731, PMID:22355110). The recombinant kinase autophosphorylates and phosphorylates an eIF-2α substrate peptide, activities inhibited by haemin, and it is expressed as 80 and 90 kDa forms across intraerythrocytic development with apical-complex localization co-localizing with AMA-1 in segmenters and merozoites (PMID:9371731). Genetic disruption established that PK4 activity is essential for completion of erythrocytic schizogony, with eIF2α phosphorylation repressing translation in schizonts and gametocytes (PMID:22355110, PMID:22127061). PK4 is activated downstream of ER stress: conditional loss of the ER chaperone PfGRP170 triggers PK4 activation, linking it to the unfolded protein response (PMID:31087747). PK4 is also the central kinase mediating artemisinin (ART)-induced eIF2α phosphorylation, translational repression, and parasite latency, since dominant-negative PK4 or pharmacological inhibition blocks entry into ART-induced dormancy and abolishes recrudescence in infected mice (PMID:29241041).

1. 1997 High

   Before its molecular identity was known, it was unclear whether P. falciparum possessed a dedicated eIF-2α kinase; cloning and biochemical characterization established PK4 as a functional eIF-2α kinase-related protein kinase with a regulated expression and localization pattern.

   Evidence Molecular cloning, recombinant expression in E. coli, in vitro peptide kinase assay, Western blot, and confocal microscopy in P. falciparum

   PMID:9371731

   Open questions at the time

   • Physiological substrate not confirmed in parasite at this stage
   • Functional consequence of the 80 vs 90 kDa forms not resolved
   • Significance of apical AMA-1 co-localization for kinase function unknown
2. 2011 Medium

   It was unknown which parasite kinases are indispensable for blood-stage growth; a kinome-wide disruption screen placed PK4 among kinases likely essential for erythrocytic schizogony.

   Evidence Kinome-wide reverse genetics disruption attempts with phospho-proteomic analysis in P. falciparum

   PMID:22127061

   Open questions at the time

   • Screen provides essentiality inference, not a defined PK4 mechanism
   • No PK4-specific follow-up in this study
3. 2012 High

   The in vivo substrate and cellular role were undefined; targeted genetics showed PK4 phosphorylates eIF2α at Ser59 to arrest global protein synthesis in schizonts and gametocytes, and that this activity is required for the erythrocytic cycle.

   Evidence Reverse genetics disruption/knockdown, Ser59 phosphorylation site identification, and global protein synthesis assays in P. falciparum

   PMID:22355110

   Open questions at the time

   • Upstream activating signals not defined here
   • How translational arrest is coordinated with schizogony/gametocytogenesis not resolved
4. 2017 High

   The kinase responsible for artemisinin-induced dormancy was unknown; reciprocal dominant-negative and pharmacological inhibition identified PK4 as the central kinase mediating ART-induced eIF2α phosphorylation, translational repression, latency, and recrudescence.

   Evidence Dominant-negative overexpression, pharmacological PK4 inhibition, phospho-eIF2α Western blot, and mouse recrudescence model in P. falciparum

   PMID:29241041

   Open questions at the time

   • Molecular sensor coupling ART to PK4 activation not defined
   • Structural basis of PK4 inhibition by the pharmacological agent not established
5. 2019 Medium

   The signals activating PK4 were unclear; epistasis via PfGRP170 knockdown placed PK4 downstream of ER stress/unfolded protein response signaling.

   Evidence Conditional knockdown of PfGRP170 with phospho-eIF2α readout as proxy for PK4 activation in P. falciparum

   PMID:31087747

   Open questions at the time

   • Activation inferred from phospho-eIF2α proxy rather than direct PK4 biochemistry
   • Direct physical/mechanistic link between PfGRP170 and PK4 not shown
   • Whether ER stress activation and ART activation converge on the same mechanism unresolved

• The direct molecular mechanism of PK4 activation and the structural basis for its regulation remain open.
• No structural model of PK4 in the corpus
• Direct upstream activators binding PK4 not identified
• Whether the haemin sensitivity observed in vitro reflects physiological regulation is uncharacterized